Lori Teranishi - 06 Jan 2022 Form 3 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
Director
Signature
Lori Teranishi
Issuer symbol
EMMA
Transactions as of
06 Jan 2022
Transactions value $
$0
Form type
3
Filing time
24 Jan 2022, 12:05:18 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EMMA Common stock, $0.001 par value 18,161 06 Jan 2022 By IQ PR, Inc. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 IQ PR, Inc, is a California corporation of which Ms. Teranishi is the sole shareholder and director.